Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with more than half of its revenue coming from Europe. In 2011-2012 its UK and USA sales alone were US$475 million. It has market presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania
, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. The Company has a market capitalization of over INR 21100 crore (US$3.4 billion) and an annual turnover of INR 3600 crore (US$570 million). It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 7,900 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group.
Wockhardt was founded by Habil Khorakiwala in the early 1960s. His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973. Wockhardt Ltd. was incorporated on July 8.1999.
Wockhardt is the first company outside of the US and Europe to manufacture recombinant human insulin.
Wockhardt Limited
Wockhardt Towers Bandra Kurla Complex,
, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. The Company has a market capitalization of over INR 21100 crore (US$3.4 billion) and an annual turnover of INR 3600 crore (US$570 million). It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 7,900 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group.
Wockhardt was founded by Habil Khorakiwala in the early 1960s. His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973. Wockhardt Ltd. was incorporated on July 8.1999.
Wockhardt is the first company outside of the US and Europe to manufacture recombinant human insulin.
Contact Details:-
Wockhardt Limited
Wockhardt Towers Bandra Kurla Complex,
Bandra (East)
Mumbai 400051
Maharashtra, India
Tel: +91 22 2653 4444
Mumbai 400051
Maharashtra, India
Tel: +91 22 2653 4444
Fax: +91 22 2653 4242
Also Check:-
Rate this posting:
0 comments :
Post a Comment